Current studies areing on Nexaph peptides, a innovative class of molecules exhibiting significant promise for affecting multiple disease mechanisms. Compared to existing small molecule methods, these amino acid sequences present improved targeting and minimal off-target reactions, enabling them a particularly desirable option for future therapeutic